Skip to content

Author: Joe Patterson

Quarterly Advocacy Newsletter – Q4 2023

Dear Advocates, We are excited to welcome you to the fourth edition of the Friends Advocacy Newsletter. It has been a great year working with you to create and launch this resource and we want to hear your thoughts on what you have liked, what could be improved, and what you want to see more of. We…

Watch Now: Friends of Cancer Research Annual Meeting 2023

On November 14, 2023, Friends of Cancer Research hosted our 16th Annual Meeting in Washington, D.C. Discussions at the meeting were the culmination of three working groups led by the organization over the past year, which collaboratively proposed solutions for three key challenges in oncology drug development: dose-finding in early phase trials, incorporating pragmatic elements in clinical trials, and using data from academic-led studies for regulatory decision-making.

Watch Now: Expediting Drug Development – Use of ctDNA as an Early Endpoint

On Wednesday, July 20, Friends of Cancer Research (Friends) hosted a meeting titled “Expediting Drug Development: Use of ctDNA as an Early Endpoint.” Welcoming everyone, Jeff Allen, President & CEO of Friends, provided updates regarding Friends’ ctDNA for Monitoring Treatment Response (ctMoniTR) project , a unique collaboration exploring whether changes in ctDNA levels can indicate clinical…